Landiolol, an Ultra-Short-Acting β1-Blocker, More Effectively Terminates Atrial Fibrillation Than Diltiazem After Open Heart Surgery
- 1 January 2012
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 76 (5), 1097-1101
- https://doi.org/10.1253/circj.cj-11-1332
Abstract
Recent studies have suggested that esmolol is the first choice for rate control in patients with postoperative atrial fibrillation (AF) after coronary artery bypass surgery, but side-effects of esmolol such as hypotension are problematic. To overcome this problem, landiolol, an ultra-short-acting β(1)-blocker with a less negative inotropic effect than esmolol, has been developed. The aim of the present study was to investigate whether landiolol was effective for both rate control and conversion to normal sinus rhythm (NSR). A prospective, randomized, open-label comparison between i.v. landiolol and diltiazem in patients with postoperative AF was undertaken between January 2008 and June 2009 in Japan. Of 335 patients included in the analysis, 71 patients went into AF. Among these 71 patients, conversion to NSR within 8h after onset of AF occurred in 19 of 35 patients (54.3%) in the landiolol group vs. 11 of 36 patients (30.6%) in the diltiazem group (P<0.05). The incidence of hypotension was lower in the landiolol group (4/35, 11.4%) compared with the diltiazem group (11/36, 30.6%; P<0.05). The incidence of bradycardia was also lower in the landiolol group (0%) compared with the diltiazem group (4/36, 11.1%; P<0.05). Landiolol is more effective and safer than diltiazem for patients with postoperative AF after open heart surgery.Keywords
This publication has 17 references indexed in Scilit:
- Statin for Prevention of Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting in Japanese PatientsCirculation Journal, 2010
- Prospective Comparative Study of Intravenous Cibenzoline and Disopyramide Therapy in the Treatment of Paroxysmal Atrial Fibrillation After Cardiovascular SurgeryCirculation Journal, 2010
- Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit heartsJournal of Anesthesia, 2008
- Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgeryEuropean Journal of Cardio-Thoracic Surgery, 2006
- Multicenter Survey on the Validity of the CD-ROM Guideline for Antiarrhythmic Drug Therapy Produced by the Japanese Circulation Society and the Japanese Society on ElectrocardiologyCirculation Journal, 2005
- Atrial Fibrillation after Cardiac SurgeryAnnals of Internal Medicine, 2001
- Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgeryAmerican Heart Journal, 2000
- Stroke in cardiac surgical patients: determinants and outcomeThe Annals of Thoracic Surgery, 1999
- Electrophysiologic, Cardiohemodynamic and β-Blocking Actions of a New Ultra-Short-Acting β-Blocker, ONO-1101, Assessed by the In Vivo Canine Model in Comparison with EsmololJournal of Cardiovascular Pharmacology, 1999
- γ-Adrenergic Blockade Accelerates Conversion of Postoperative Supraventricular TachyarrhythmiasAnesthesiology, 1998